Related Experiment Video
Updated: Jul 16, 2026
05:51
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
[Levodopa modifies pain thresholds in Parkinson's disease patients]
T Slaoui1, A Mas-Gerdelat, F Ory-Magne
1Service de Neurologie, CHU, Toulouse. tarikslaoui@yahoo.com
Revue Neurologique
|February 17, 2007
Summary
Levodopa treatment significantly increased heat and cold pain thresholds in Parkinson's disease (PD) patients. This suggests dopaminergic drugs may offer analgesic benefits for PD-related pain.
Area of Science:
- Neurology
- Pain Medicine
- Pharmacology
Context:
- Parkinson's disease (PD) is a neurodegenerative disorder often associated with altered pain perception.
- Dopaminergic pathways play a role in both motor control and pain modulation.
- The analgesic effects of levodopa in PD patients require further elucidation.
Purpose:
- To investigate the impact of levodopa dosage on thermal pain thresholds in individuals with Parkinson's disease.
- To quantify changes in heat and cold pain sensitivity during dopaminergic medication (ON) versus withdrawal (OFF) states.
Summary:
- Twenty Parkinson's disease patients underwent thermal nociceptive stimulation in both ON (levodopa administered) and OFF (levodopa withdrawn) conditions.
- Heat pain thresholds were significantly higher in the ON state compared to the OFF state across two assessment methods (p=0.02).
- Cold pain thresholds and heat pain tolerance also showed statistically significant increases in the ON state versus OFF state (p=0.02).
Impact:
- Levodopa administration demonstrably enhances heat and cold pain thresholds in Parkinson's disease patients.
- These findings indicate a potential analgesic effect of dopaminergic therapy for pain experienced by PD patients.
- This research supports the role of dopaminergic modulation in managing pain symptoms within the context of Parkinson's disease.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.